{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T18:36:08Z","timestamp":1787337368208,"version":"build-2736575974"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T00:00:00Z","timestamp":1784937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T00:00:00Z","timestamp":1787270400000},"content-version":"vor","delay-in-days":27,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82002580"],"award-info":[{"award-number":["82002580"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82470237"],"award-info":[{"award-number":["82470237"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Commission-University Joint Innovation Fund, Affiliated Hospital of Chengdu University of Traditional Chinese Medicine\/Sichuan Provincial Hospital of Traditional Chinese Medicine","award":["WXLH202501024"],"award-info":[{"award-number":["WXLH202501024"]}]},{"name":"Postdoctoral Project of the Sichuan Provincial Human Resources and Social Security Department","award":["TB2023018"],"award-info":[{"award-number":["TB2023018"]}]},{"DOI":"10.13039\/100007452","name":"Wu Jieping Medical Foundation","doi-asserted-by":"publisher","award":["320.6750.2024-13-98"],"award-info":[{"award-number":["320.6750.2024-13-98"]}],"id":[{"id":"10.13039\/100007452","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Chinese Foundation for the Development of Medical and Health Services","award":["chmdf2024-xrzx09-10"],"award-info":[{"award-number":["chmdf2024-xrzx09-10"]}]},{"name":"National Natural Science Foundation of China, Regional Innovation and Development Joint Fund","award":["U24A20679"],"award-info":[{"award-number":["U24A20679"]}]},{"name":"Cancer Innovative Research Program of Sun Yat-sen University Cancer Center","award":["CIRP-SYSUCC-0022"],"award-info":[{"award-number":["CIRP-SYSUCC-0022"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-026-05557-1","type":"journal-article","created":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T16:04:39Z","timestamp":1784995479000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Identification of disulfidptosis-related molecular subtypes in pleural mesothelioma demonstrates a correlation with the immune infiltration, prognosis and therapy efficacy"],"prefix":"10.1007","volume":"17","author":[{"given":"Jing","family":"Ding","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuefeng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenxiu","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tongyu","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,25]]},"reference":[{"issue":"11","key":"5557_CR1","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1007\/s11912-022-01302-3","volume":"24","author":"ND Perera","year":"2022","unstructured":"Perera ND, Mansfield AS. The Evolving Therapeutic Landscape for Malignant Pleural Mesothelioma. Curr Oncol Rep. 2022;24(11):1413\u201323.","journal-title":"Curr Oncol Rep"},{"issue":"11","key":"5557_CR2","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1097\/JTO.0b013e3181f1cf2b","volume":"5","author":"MT Milano","year":"2010","unstructured":"Milano MT, Zhang H. Malignant pleural mesothelioma: a population-based study of survival. J Thorac Oncol. 2010;5(11):1841\u20138.","journal-title":"J Thorac Oncol"},{"issue":"2","key":"5557_CR3","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.lungcan.2014.08.017","volume":"86","author":"AS Mansfield","year":"2014","unstructured":"Mansfield AS, Symanowski JT, Peikert T. Systematic review of response rates of sarcomatoid malignant pleural mesotheliomas in clinical trials. Lung Cancer. 2014;86(2):133\u20136.","journal-title":"Lung Cancer"},{"issue":"1","key":"5557_CR4","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.jss.2015.01.043","volume":"196","author":"RR Meyerhoff","year":"2015","unstructured":"Meyerhoff RR, Yang CF, Speicher PJ, Gulack BC, Hartwig MG, D\u2019Amico TA, et al. Impact of mesothelioma histologic subtype on outcomes in the Surveillance, Epidemiology, and End Results database. J Surg Res. 2015;196(1):23\u201332.","journal-title":"J Surg Res"},{"issue":"6","key":"5557_CR5","doi-asserted-by":"publisher","first-page":"1900953","DOI":"10.1183\/13993003.00953-2019","volume":"55","author":"A Scherpereel","year":"2020","unstructured":"Scherpereel A, Opitz I, Berghmans T, Psallidas I, Glatzer M, Rigau D, et al. ERS\/ESTS\/EACTS\/ESTRO guidelines for the management of malignant pleural mesothelioma. Eur Respir J. 2020;55(6):1900953.","journal-title":"Eur Respir J"},{"issue":"11","key":"5557_CR6","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1002\/gcc.22670","volume":"57","author":"M Betti","year":"2018","unstructured":"Betti M, Aspesi A, Ferrante D, Sculco M, Righi L, Mirabelli D, et al. Sensitivity to asbestos is increased in patients with mesothelioma and pathogenic germline variants in BAP1 or other DNA repair genes. Genes Chromosomes Cancer. 2018;57(11):573\u201383.","journal-title":"Genes Chromosomes Cancer"},{"issue":"3","key":"5557_CR7","doi-asserted-by":"publisher","first-page":"934","DOI":"10.21037\/tlcr-2019-pps-10","volume":"9","author":"A Hjerpe","year":"2020","unstructured":"Hjerpe A, Abd Own S, Dobra K. Integrative approach to cytologic and molecular diagnosis of malignant pleural mesothelioma. Transl Lung Cancer Res. 2020;9(3):934\u201343.","journal-title":"Transl Lung Cancer Res"},{"key":"5557_CR8","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.semcancer.2019.09.014","volume":"61","author":"TK Hinz","year":"2020","unstructured":"Hinz TK, Heasley LE. Translating mesothelioma molecular genomics and dependencies into precision oncology-based therapies. Semin Cancer Biol. 2020;61:11\u201322.","journal-title":"Semin Cancer Biol"},{"issue":"6","key":"5557_CR9","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1200\/JCO.21.01567","volume":"40","author":"AS Tsao","year":"2022","unstructured":"Tsao AS, Pass HI, Rimner A, Mansfield AS. New Era for Malignant Pleural Mesothelioma: Updates on Therapeutic Options. J Clin Oncol. 2022;40(6):681\u201392.","journal-title":"J Clin Oncol"},{"issue":"2","key":"5557_CR10","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/s41573-021-00339-6","volume":"21","author":"ZE Stine","year":"2022","unstructured":"Stine ZE, Schug ZT, Salvino JM, Dang CV. Targeting cancer metabolism in the era of precision oncology. Nat Rev Drug Discov. 2022;21(2):141\u201362.","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"5557_CR11","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s13046-023-02675-4","volume":"42","author":"PJ Zheng","year":"2023","unstructured":"Zheng PJ, Zhou CT, Ding YM, Duan SW. Disulfidptosis: a new target for metabolic cancer therapy. J Exp Clin Cancer Res. 2023;42(1):103.","journal-title":"J Exp Clin Cancer Res"},{"issue":"3","key":"5557_CR12","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1038\/s41556-023-01091-2","volume":"25","author":"XG Liu","year":"2023","unstructured":"Liu XG, Nie LT, Zhang YL, Yan YL, Wang C, Colic M, et al. Actin cytoskeleton vulnerability to disulfide stress mediates disulfidptosis. Nat Cell Biol. 2023;25(3):404\u201314.","journal-title":"Nat Cell Biol"},{"key":"5557_CR13","doi-asserted-by":"publisher","first-page":"110368","DOI":"10.1016\/j.intimp.2023.110368","volume":"120","author":"T Wang","year":"2023","unstructured":"Wang T, Guo K, Zhang D, Wang H, Yin J, Cui H, et al. Disulfidptosis classification of hepatocellular carcinoma reveals correlation with clinical prognosis and immune profile. Int Immunopharmacol. 2023;120:110368.","journal-title":"Int Immunopharmacol"},{"key":"5557_CR14","doi-asserted-by":"publisher","first-page":"1205250","DOI":"10.3389\/fimmu.2023.1205250","volume":"14","author":"K Xu","year":"2023","unstructured":"Xu K, Zhang Y, Yan Z, Wang Y, Li Y, Qiu Q, et al. Identification of disulfidptosis related subtypes, characterization of tumor microenvironment infiltration, and development of DRG prognostic prediction model in RCC, in which MSH3 is a key gene during disulfidptosis. Front Immunol. 2023;14:1205250.","journal-title":"Front Immunol"},{"key":"5557_CR15","doi-asserted-by":"publisher","first-page":"1180404","DOI":"10.3389\/fendo.2023.1180404","volume":"14","author":"S Zhao","year":"2023","unstructured":"Zhao S, Wang L, Ding W, Ye B, Cheng C, Shao J, et al. Crosstalk of disulfidptosis-related subtypes, establishment of a prognostic signature and immune infiltration characteristics in bladder cancer based on a machine learning survival framework. Front Endocrinol (Lausanne). 2023;14:1180404.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"5557_CR16","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1186\/s12967-022-03744-6","volume":"20","author":"T Meirson","year":"2022","unstructured":"Meirson T, Nardone V, Pentimalli F, Markel G, Bomze G, D\u2019Apolito M, Correale P, Giordano A, Pirtoli L, Porta C, Gray SG, Mutti L. Analysis of new treatments proposed for malignant pleural mesothelioma raises concerns about the conduction of clinical trials in oncology. J Transl Med. 2022;20(1):593.","journal-title":"J Transl Med"},{"issue":"3","key":"5557_CR17","doi-asserted-by":"publisher","first-page":"e221490","DOI":"10.1001\/jamanetworkopen.2022.1490","volume":"5","author":"T Meirson","year":"2022","unstructured":"Meirson T, Pentimalli F, Cerza F, Baglio G, Gray SG, Correale P, Krstic-Demonacos M, Markel G, Giordano A, Bomze D, Mutti L. Comparison of 3 Randomized Clinical Trials of Frontline Therapies for Malignant Pleural Mesothelioma. JAMA Netw Open. 2022;5(3):e221490.","journal-title":"JAMA Netw Open"},{"key":"5557_CR18","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.lungcan.2022.01.016","volume":"165","author":"L Cantini","year":"2022","unstructured":"Cantini L, Laniado I, Murthy V, Sterman D, Aerts J. Immunotherapy for mesothelioma: Moving beyond single immune check point inhibition. Lung Cancer. 2022;165:91\u2013101.","journal-title":"Lung Cancer"},{"issue":"1","key":"5557_CR19","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1097\/CCO.0000000000000697","volume":"33","author":"K Sinn","year":"2021","unstructured":"Sinn K, Mosleh B, Hoda MA. Malignant pleural mesothelioma: recent developments. Curr Opin Oncol. 2021;33(1):80\u20136.","journal-title":"Curr Opin Oncol"},{"key":"5557_CR20","unstructured":"McNamee N, Harvey C, Gray L, Khoo T, Lingam L, Zhang B, Nindra U, Yip PY, Pal A, Clay T, Arulananda S, Itchins M, Pavlakis N, Kao S, Bowyer S, Chin V, Warburton L, Silva IP, John J, Solomon B, Alexander M, Nagrial A. Brief Report: Real-world toxicity and survival of combination immunotherapy in pleural mesothelioma - RIOMeso. J Thorac Oncol. 2023:S1556-0864(23)02370-5."},{"issue":"4","key":"5557_CR21","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.jtho.2024.01.016","volume":"19","author":"GG Steven","year":"2024","unstructured":"Steven GG, Tomer M, Luciano M. Based on the Real-World Results From Australia, Immunotherapy Is Not a Good Option for Patients With Mesothelioma. J Thorac Oncol. 2024;19(4):541\u20136.","journal-title":"J Thorac Oncol"},{"issue":"4","key":"5557_CR22","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.jtho.2024.01.017","volume":"19","author":"I Smesseim","year":"2024","unstructured":"Smesseim I, Baas P. Immunotherapy Is a Good Standard Option for Patients with Malignant Pleural Mesothelioma, Despite the Real-World Results from Australia. J Thorac Oncol. 2024;19(4):547\u201350.","journal-title":"J Thorac Oncol"},{"issue":"1","key":"5557_CR23","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1038\/s41416-019-0661-9","volume":"122","author":"L Urso","year":"2020","unstructured":"Urso L, Cavallari I, Sharova E, Ciccarese F, Pasello G, Ciminale V. Metabolic rewiring and redox alterations in malignant pleural mesothelioma. Br J Cancer. 2020;122(1):52\u201361.","journal-title":"Br J Cancer"},{"issue":"13","key":"5557_CR24","doi-asserted-by":"publisher","first-page":"3059","DOI":"10.3390\/cancers14133059","volume":"14","author":"S Li","year":"2022","unstructured":"Li S, Lu Z, Sun R, Guo S, Gao F, Cao B, et al. The Role of SLC7A11 in Cancer: Friend or Foe? Cancers (Basel). 2022;14(13):3059.","journal-title":"Cancers (Basel)"},{"issue":"5","key":"5557_CR25","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1111\/j.1349-7006.2012.02223.x","volume":"103","author":"Y Yoshikawa","year":"2012","unstructured":"Yoshikawa Y, Sato A, Tsujimura T, Emi M, Morinaga T, Fukuoka K, Yamada S, et al. Frequent inactivation of the BAP1 gene in epithelioid-type malignant mesothelioma. Cancer Sci. 2012;103(5):868\u201374.","journal-title":"Cancer Sci"},{"issue":"7659","key":"5557_CR26","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1038\/nature22798","volume":"546","author":"A Bononi","year":"2017","unstructured":"Bononi A, Giorgi C, Patergnani S, Larson D, Verbruggen K, Tanji M, et al. BAP1 regulates IP3R3-mediated Ca(2+) flux to mitochondria suppressing cell transformation. Nature. 2017;546(7659):549\u201353.","journal-title":"Nature"},{"issue":"7519","key":"5557_CR27","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/nature13490","volume":"513","author":"OR Colegio","year":"2014","unstructured":"Colegio OR, Chu NQ, Szabo AL, Chu T, Rhebergen AM, Jairam V, et al. Functional polarization of tumour-associated macrophages by tumour-derived lactic acid. Nature. 2014;513(7519):559\u201363.","journal-title":"Nature"},{"issue":"1","key":"5557_CR28","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s12964-022-00854-y","volume":"20","author":"A Naimi","year":"2022","unstructured":"Naimi A, Mohammed RN, Raji A, Chupradit S, Yumashev AV, Suksatan W, et al. Tumor immunotherapies by immune checkpoint inhibitors (ICIs); the pros and cons. Cell Commun Signal. 2022;20(1):44.","journal-title":"Cell Commun Signal"},{"issue":"1","key":"5557_CR29","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1007\/s11033-021-06869-x","volume":"49","author":"YT Zhao","year":"2022","unstructured":"Zhao YT, Zhang H, Wang HB, Ye M, Jin XF. Role of formin INF2 in human diseases. Mol Biol Rep. 2022;49(1):735\u201346.","journal-title":"Mol Biol Rep"},{"issue":"11","key":"5557_CR30","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.3390\/cells8111427","volume":"8","author":"D Tentler","year":"2019","unstructured":"Tentler D, Lomert E, Novitskaya K, Barlev NA. Role of ACTN4 in Tumorigenesis, Metastasis, and EMT. Cells. 2019;8(11):1427.","journal-title":"Cells"},{"issue":"8","key":"5557_CR31","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1080\/15384101.2019.1597506","volume":"18","author":"YL Zhang","year":"2019","unstructured":"Zhang YL, Koppula P, Gan B. Regulation of H2A ubiquitination and SLC7A11 expression by BAP1 and PRC1. Cell Cycle. 2019;18(8):773\u201383.","journal-title":"Cell Cycle"},{"issue":"8","key":"5557_CR32","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1158\/0008-5472.CAN-18-3037","volume":"79","author":"T Liu","year":"2019","unstructured":"Liu T, Jiang L, Tavana O, Gu W. The Deubiquitylase OTUB1 Mediates Ferroptosis via Stabilization of SLC7A11. Cancer Res. 2019;79(8):1913\u201324.","journal-title":"Cancer Res"},{"issue":"3","key":"5557_CR33","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/cdd.2015.158","volume":"23","author":"Y Xie","year":"2016","unstructured":"Xie Y, Hou W, Song X, Yu Y, Huang J, Sun X, et al. Ferroptosis: process and function. Cell Death Differ. 2016;23(3):369\u201379.","journal-title":"Cell Death Differ"},{"issue":"3","key":"5557_CR34","first-page":"372","volume":"35","author":"I Vitale","year":"2023","unstructured":"Vitale I, Manic G, Coussens LM, Kroemer G, Galluzzi L. Macrophages and Metabolism in the Tumor Microenvironment. Cell Metab. 2023;35(3):372\u201388.","journal-title":"Cell Metab"},{"key":"5557_CR35","doi-asserted-by":"publisher","first-page":"566511","DOI":"10.3389\/fonc.2020.566511","volume":"10","author":"I Larionova","year":"2020","unstructured":"Larionova I, Tuguzbaeva G, Ponomaryova A, et al. Tumor-associated macrophages in human breast, colorectal, lung, ovarian and prostate cancers. Front Oncol. 2020;10:566511.","journal-title":"Front Oncol"},{"issue":"1","key":"5557_CR36","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.immuni.2014.06.010","volume":"41","author":"N Roy","year":"2014","unstructured":"Roy N, Jeffrey WP. Tumor-associated macrophages: from mechanisms to therapy. Immunity. 2014;41(1):49\u201361.","journal-title":"Immunity"},{"issue":"389","key":"5557_CR37","doi-asserted-by":"publisher","first-page":"eaal3604","DOI":"10.1126\/scitranslmed.aal3604","volume":"9","author":"PA Sean","year":"2017","unstructured":"Sean PA, Christopher SG, Rainer HK, et al. In vivo imaging reveals a tumor-associated macrophage mediated resistance pathway in anti-PD-1 therapy. Sci Transl Med. 2017;9(389):eaal3604.","journal-title":"Sci Transl Med"},{"issue":"17","key":"5557_CR38","first-page":"E4041","volume":"24","author":"P Elisa","year":"2018","unstructured":"Elisa P, Jean L, Lene V, et al. Macrophages impede CD8 T cells from reaching tumor cells and limit the efficacy of anti-PD-1 treatment. Proc Natl Acad Sci USA. 2018;24(17):E4041\u201350.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6282","key":"5557_CR39","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1126\/science.aaf4405","volume":"352","author":"EB Rankin","year":"2016","unstructured":"Rankin EB, Giaccia AJ. Hypoxic control of metastasis. Science. 2016;352(6282):175\u201380.","journal-title":"Science"},{"issue":"3","key":"5557_CR40","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/s41577-020-0406-2","volume":"21","author":"M Certo","year":"2021","unstructured":"Certo M, Tsai CH, Pucino V, et al. Lactate modulation of immune responses in inflammatory versus tumor microenvironments. Nat Rev Immunol. 2021;21(3):151\u201361.","journal-title":"Nat Rev Immunol"},{"key":"5557_CR41","first-page":"678766","volume":"12","author":"X Yu","year":"2021","unstructured":"Yu X, Wang Y, Zhou J, et al. Emerging role of STAT3 in macrophage polarization: predictive biomarker and therapeutic target in cancer. Front Immunol. 2021;12:678766.","journal-title":"Front Immunol"},{"issue":"35","key":"5557_CR42","doi-asserted-by":"publisher","first-page":"14978","DOI":"10.1073\/pnas.0809784106","volume":"106","author":"C Porta","year":"2009","unstructured":"Porta C, Rimoldi M, Raes G, et al. Tolerance and M2 (alternative) macrophage polarization are related processes orchestrated by p50 nuclear factor kappaB. Proc Natl Acad Sci USA. 2009;106(35):14978\u201383.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"5557_CR43","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.immuni.2018.01.010","volume":"48","author":"A Glasner","year":"2018","unstructured":"Glasner A, Levi A, Enk J, Isaacson B, Viukov S, Orlanski S, Scope A, et al. NKp46 Receptor-Mediated Interferon-\u03b3 Production by Natural Killer Cells Increases Fibronectin 1 to Alter Tumor Architecture and Control Metastasis. Immunity. 2018;48(2):396\u20138.","journal-title":"Immunity"},{"issue":"2","key":"5557_CR44","doi-asserted-by":"publisher","first-page":"e1364827","DOI":"10.1080\/2162402X.2017.1364827","volume":"7","author":"S Maurer","year":"2017","unstructured":"Maurer S, Kropp KN, Klein G, Steinle A, Haen SP, Walz JS, et al. Platelet-mediated shedding of NKG2D ligands impairs NK cell immune-surveillance of tumor cells. Oncoimmunology. 2017;7(2):e1364827.","journal-title":"Oncoimmunology"},{"issue":"1","key":"5557_CR45","doi-asserted-by":"publisher","first-page":"86","DOI":"10.4161\/15384101.2014.974419","volume":"14","author":"YA Shen","year":"2015","unstructured":"Shen YA, Wang CY, Hsieh YT, Chen YJ, Wei YH. Metabolic reprogramming orchestrates cancer stem cell properties in nasopharyngeal carcinoma. Cell Cycle. 2015;14(1):86\u201398.","journal-title":"Cell Cycle"},{"issue":"1","key":"5557_CR46","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.cmet.2015.12.004","volume":"23","author":"CL Chen","year":"2016","unstructured":"Chen CL, Uthaya Kumar DB, Punj V, Xu J, Sher L, Tahara SM, et al. NANOG Metabolically Reprograms Tumor-Initiating Stem-like Cells through Tumorigenic Changes in Oxidative Phosphorylation and Fatty Acid Metabolism. Cell Metab. 2016;23(1):206\u201319.","journal-title":"Cell Metab"},{"issue":"4","key":"5557_CR47","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1016\/j.cmet.2015.08.015","volume":"22","author":"P Sancho","year":"2015","unstructured":"Sancho P, Burgos-Ramos E, Tavera A, Bou Kheir T, Jagust P, Schoenhals M, et al. MYC\/PGC-1\u03b1 Balance Determines the Metabolic Phenotype and Plasticity of Pancreatic Cancer Stem Cells. Cell Metab. 2015;22(4):590\u2013605.","journal-title":"Cell Metab"},{"issue":"12","key":"5557_CR48","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1038\/bjc.2016.152","volume":"114","author":"P Sancho","year":"2016","unstructured":"Sancho P, Barneda D, Heeschen C. Hallmarks of cancer stem cell metabolism. Br J Cancer. 2016;114(12):1305\u201312.","journal-title":"Br J Cancer"},{"issue":"1","key":"5557_CR49","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1002\/ijc.32419","volume":"146","author":"M Vladan","year":"2020","unstructured":"Vladan M, Joanna K, Iris CS, Roberta L, Francesca N, et al. Wnt\/IL-1\u03b2\/IL-8 autocrine circuitries control chemoresistance in mesothelioma initiating cells by inducing ABCB5. Int J Cancer. 2020;146(1):192\u2013207.","journal-title":"Int J Cancer"},{"issue":"2","key":"5557_CR50","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.cell.2018.03.034","volume":"173","author":"TM Malta","year":"2018","unstructured":"Malta TM, Sokolov A, Gentles AJ, Burzykowski T, Poisson L, Weinstein JN, et al. Machine Learning Identifies Stemness Features Associated with Oncogenic Dedifferentiation. Cell. 2018;173(2):338\u2013e35415.","journal-title":"Cell"},{"issue":"10","key":"5557_CR51","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1038\/s41591-018-0136-1","volume":"24","author":"P Jiang","year":"2018","unstructured":"Jiang P, et al. Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response. Nat Med. 2018;24(10):1550\u20138.","journal-title":"Nat Med"},{"issue":"10272","key":"5557_CR52","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/S0140-6736(20)32714-8","volume":"397","author":"P Baas","year":"2021","unstructured":"Baas P, et al. First-line nivolumab plus ipilimumab in unresectable malignant pleural mesothelioma (CheckMate 743): a multicentre, randomised, open-label, phase 3 trial. Lancet. 2021;397(10272):375\u201386.","journal-title":"Lancet"},{"issue":"10419","key":"5557_CR53","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.1016\/S0140-6736(23)01613-6","volume":"402","author":"Q Chu","year":"2023","unstructured":"Chu Q, et al. Pembrolizumab plus chemotherapy versus chemotherapy in untreated advanced pleural mesothelioma in Canada, Italy, and France: a phase 3, open-label, randomised controlled trial. Lancet. 2023;402(10419):2295\u2013306.","journal-title":"Lancet"},{"issue":"26","key":"5557_CR54","doi-asserted-by":"publisher","first-page":"2509","DOI":"10.1056\/NEJMoa1500596","volume":"372","author":"DT Le","year":"2015","unstructured":"Le DT, et al. PD-1 Blockade in Tumors with Mismatch-Repair Deficiency. N Engl J Med. 2015;372(26):2509\u201320.","journal-title":"N Engl J Med"},{"issue":"4","key":"5557_CR55","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/ng.3520","volume":"48","author":"R Bueno","year":"2016","unstructured":"Bueno R, et al. Comprehensive genomic analysis of malignant pleural mesothelioma identifies recurrent mutations, gene fusions and splicing alterations. Nat Genet. 2016;48(4):407\u201316.","journal-title":"Nat Genet"},{"issue":"6230","key":"5557_CR56","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1126\/science.aaa6204","volume":"348","author":"JA Joyce","year":"2015","unstructured":"Joyce JA, Fearon DT. T cell exclusion, immune privilege, and the tumor microenvironment. Science. 2015;348(6230):74\u201380.","journal-title":"Science"},{"issue":"24","key":"5557_CR57","doi-asserted-by":"publisher","first-page":"3409","DOI":"10.1101\/gad.1735208","volume":"22","author":"T Shimi","year":"2008","unstructured":"Shimi T, Pfleghaar K, Kojima S-i, Pack C-G, Solovei I, Goldman AE, Adam SA, et al. The A- and B-type nuclear lamin networks: microdomains involved in chromatin organization and transcription. Genes Dev. 2008;22(24):3409\u201321.","journal-title":"Genes Dev"},{"issue":"4","key":"5557_CR58","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1002\/jcb.22992","volume":"112","author":"NM Maraldi","year":"2011","unstructured":"Maraldi NM, Capanni C, Cenni V, Fini M, Lattanzi G. Laminopathies and lamin-associated signaling pathways. J Cell Biochem. 2011;112(4):979\u201392.","journal-title":"J Cell Biochem"},{"issue":"1\u20132","key":"5557_CR59","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s00412-013-0399-8","volume":"122","author":"DN Simon","year":"2013","unstructured":"Simon DN, Wilson KL. Partners and post-translational modifications of nuclear lamins. Chromosoma. 2013;122(1\u20132):13\u201331.","journal-title":"Chromosoma"},{"issue":"24","key":"5557_CR60","doi-asserted-by":"publisher","first-page":"e00274","DOI":"10.1128\/MCB.00274-17","volume":"37","author":"A Sen Gupta","year":"2017","unstructured":"Sen Gupta A, Sengupta K. Lamin B2 Modulates Nucleolar Morphology, Dynamics, and Function. Mol Cell Biol. 2017;37(24):e00274\u201317.","journal-title":"Mol Cell Biol"},{"issue":"1","key":"5557_CR61","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.tcb.2017.08.004","volume":"28","author":"R de Leeuw","year":"2018","unstructured":"de Leeuw R, Gruenbaum Y, Medalia O. Nuclear Lamins: thin Filaments with Major Functions. Trends Cell Biol. 2018;28(1):34\u201345.","journal-title":"Trends Cell Biol"},{"key":"5557_CR62","doi-asserted-by":"publisher","first-page":"147423","DOI":"10.1016\/j.gene.2023.147423","volume":"870","author":"Y Li","year":"2023","unstructured":"Li Y, Zhu J, Yu Z, Li H, Jin X. The role of lamin B2 in human diseases. Gene. 2023;870:147423.","journal-title":"Gene"},{"key":"5557_CR63","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1007\/978-1-4899-8032-8_18","volume":"773","author":"P Vagnarelli","year":"2014","unstructured":"Vagnarelli P. Repo-man at the intersection of chromatin remodelling, DNA repair, nuclear envelope organization, and cancer progression. Adv Exp Med Biol. 2014;773:401\u201314.","journal-title":"Adv Exp Med Biol"},{"key":"5557_CR64","doi-asserted-by":"crossref","unstructured":"Bruno G, Komal D, William Z et al. Single-Cell View of Tumor Microenvironment Gradients in Pleural Mesothelioma. Cancer Discov. 2024 1;14(11):2262\u20132278.","DOI":"10.1158\/2159-8290.CD-23-0017"},{"issue":"2","key":"5557_CR65","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1007\/s00204-024-03910-3","volume":"99","author":"C Zhang","year":"2025","unstructured":"Zhang C, Shi D, Lai GC, et al. A transcriptome-wide association study integrating multi-omics bioinformatics and Mendelian randomization reveals the prognostic value of ADAMDEC1 in colon cancer. Arch Toxicol. 2025;99(2):645\u201365.","journal-title":"Arch Toxicol"},{"issue":"9","key":"5557_CR66","doi-asserted-by":"publisher","first-page":"2620","DOI":"10.1007\/s12033-023-01045-x","volume":"66","author":"C Zhang","year":"2024","unstructured":"Zhang C, Lai GC, Deng JL, et al. Integrating Machine Learning and Mendelian Randomization Determined a Functional Neurotrophin-Related Gene Signature in Patients with Lower-Grade Glioma. Mol Biotechnol. 2024;66(9):2620\u201334.","journal-title":"Mol Biotechnol"},{"issue":"4","key":"5557_CR67","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/j.immuni.2018.03.023","volume":"48","author":"V Thorsson","year":"2018","unstructured":"Thorsson V, Gibbs DL, Brown SD, Wolf D, Bortone DS, Ou Yang TH, et al. The Immune Landscape of Cancer. Immunity. 2018;48(4):812\u2013e83014.","journal-title":"Immunity"},{"key":"5557_CR68","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa M, Goto S. KEGG: Kyoto Encyclopedia of Genes and Genomes. Nucleic Acids Res. 2000;28:27\u201330.","journal-title":"Nucleic Acids Res"},{"key":"5557_CR69","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1002\/pro.3715","volume":"28","author":"M Kanehisa","year":"2019","unstructured":"Kanehisa M. Toward understanding the origin and evolution of cellular organisms. Protein Sci. 2019;28:1947\u201351.","journal-title":"Protein Sci"},{"key":"5557_CR70","doi-asserted-by":"publisher","first-page":"D587","DOI":"10.1093\/nar\/gkac963","volume":"51","author":"M Kanehisa","year":"2023","unstructured":"Kanehisa M, Furumichi M, Sato Y, Kawashima M, Ishiguro-Watanabe M. KEGG for taxonomy-based analysis of pathways and genomes. Nucleic Acids Res. 2023;51:D587\u201392.","journal-title":"Nucleic Acids Res"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-026-05557-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-05557-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-05557-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T18:02:52Z","timestamp":1787335372000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-026-05557-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,25]]},"references-count":70,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5557"],"URL":"https:\/\/doi.org\/10.1007\/s12672-026-05557-1","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,25]]},"assertion":[{"value":"13 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable, as no individual or identifiable personal data are included in this study.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1226"}}